Skip to main content
ImmuneCited

Beta-Glucan untuk Upper Respiratory Tract Infections

A

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dbeta\u002Dglucan\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Kesimpulan

Meta-analysis of 13 randomized controlled trials shows yeast beta-glucan may help reduce the incidence, number of episodes, and duration of upper respiratory tract infections compared to placebo. A 16-week RCT with 162 participants found 25% reduction in symptomatic cold infections.

Key Study Findings

Randomized Controlled Trial
The anti-infective effect of β-glucans in children.
Dose: 10 mg vs: Placebo Outcome: Body weight Efek: None None

Populasi: None

In Vitro
Dry blood spot samples to monitor immune-associated mRNA expression in intervention studies: Impact of Baker's …
Dose: 250 mg/d vs: None Outcome: oxidative stress markers Efek: None None

Populasi: None

Randomized Controlled Trial 12 weeks Double-blind
β -Glucan Improves Protective Qi Status in Adults with Protective Qi Deficiency-A Randomized, Placebo-Controlled, and …
Dose: None vs: Placebo Outcome: Protective Qi status improvement Efek: None None

Populasi: Adults with Protective Qi deficiency

Meta-Analysis
Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in …
Dose: 95% vs: placebo Outcome: None Efek: OR = 0.345 p < 0.001

Populasi: healthy subjects

Randomized Controlled Trial n=69
Soluble and Insoluble Yeast β-Glucan Differentially Affect Upper Respiratory Tract Infection in Marathon Runners: A …
Dose: 250 mL/d vs: Placebo Outcome: None Efek: None None

Populasi: URTI patients

Randomized Controlled Trial n=132 Double-blind
Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled …
Dose: 250 mL/d vs: Placebo Outcome: None Efek: None p < .05

Populasi: URTI patients

Key Statistics

13

Studi

2000

Peserta

Positive

A

Peringkat

Referenced Papers

International journal for … 2024 5 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:
250-500 mg/day
immunesupport:
250-750 mg/day

Batas atas: No established UL

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
10 mg -- Positive --
250 mg/d -- Positive --
None 12 weeks Positive --
95% -- Positive --
250 mL/d -- Mixed 69
250 mL/d -- Neutral 132
900 mg 16.0 weeks Positive 299
367 mg 12.9 weeks Positive 34

Waktu terbaik diminum: On empty stomach for optimal immune activation

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Generally very well tolerated
  • Mild gastrointestinal effects (bloating)
  • Allergic reactions in yeast-sensitive individuals

Interaksi yang Diketahui

  • Immunosuppressant medications (may counteract immunosuppression)
  • Generally few known drug interactions

Asupan atas yang dapat ditoleransi: No established UL

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Beta-Glucan help with Upper Respiratory Tract Infections?
Based on 13 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Beta-Glucan may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Beta-Glucan should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Beta-Glucan?
Reported side effects may include Generally very well tolerated, Mild gastrointestinal effects (bloating), Allergic reactions in yeast-sensitive individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Beta-Glucan and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 13 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.